Platelet Rich Therapy for Scar Revision

Rejuva Medical Aesthetics

Status: Unknown

Conditions: Abdominoplasty Scar Revision

Treatments: Other: Platelet Rich Plasma; Other: Platelet Rich Fibrin

Study type: Interventional

Funder types: Other

Identifiers

NCT03555357

PRF02

Details and patient eligibility

About

This study will evaluate the efficacy of platelet injections for use of scar therapy post abdominoplasty operations.

Full description

Platelet therapy is quickly becoming an integral aspect of both medical and cosmetic procedures. Most notably, Platelet Rich Plasma (PRP) has been used in surgical settings to stimulate healing and promote tissue regeneration. In the field of cosmetic medicine, PRP has been used topically or as an injection to stimulate collagen production and enhance the efficacy of cosmetic procedures such as fat transfer, hair loss therapies, laser treatments, and microneedling. Harvested PRP has platelets, fibrin, and white blood cells, which contribute to wound healing, neocollagenesis, and elastogenesis. Platelet Rich Fibrin (PRF) is the next generation of PRP and contains very high concentrations white blood cells, fibrin and a small amount of mesenchymal stem cells found circulating in our bloodstreams. Due to a lack of anticoagulant in the tube, PRF becomes a gel after 15-20 minutes of being isolated. These properties make PRF useful in reconstructive and aesthetic medicine but may also be beneficial for scar therapy in the same way PRP is currently used.The purpose of this study is to evaluate the efficacy of platelet rich plasma vs. platelet rich fibrin for scar therapy in abdominoplasty who are at least one-year post operation.

Enrollment: 10 estimated patients

Sex: All

Ages: 18 to 80 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Ten (10) subjects
• male and female abdominoplasty procedures at least one year ago.
• must be able to provide healthy blood sample
• must be available for the duration of the study and all follow ups (12 months).

Exclusion criteria

• Pregnant and breast-feeding patients are not eligible for this study due to unstudied effects of injectables on the growing fetus and/or breast milk.
• patients who have undergone other scar therapies for the same scar.
• chronic health problems that may prevent the investigators from obtaining a viable blood sample,
• topical infection,
• any subjects who intend to have other scar procedures during the timeline of the study (12 months including punch biopsy procedures 3 months post treatment and 6 months post treatment).

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

10 participants in 2 patient groups

PRP

Active Comparator group

Description:

Platelet Rich Plasma (PRP) injections into one half of the scar will be preformed. PRP is already considered an effective treatment for scar therapy.This will be randomly assigned by the clinical research coordinator .

Treatment:

Other: Platelet Rich Plasma

PRF

Experimental group

Description:

Platelet Rich Fibrin (PRF) injections will be preformed the other half of the scar that is not treated with PRP. PRF has not been established as an effective scar treatment. The PRF will be considered experimental as this study seeks to evaluate if it is more effective than PRP.

Treatment:

Other: Platelet Rich Fibrin